FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/05/087643 [Registered on: 26/05/2025] Trial Registered Prospectively
Last Modified On: 16/05/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   To Compare the result of Gomutra haritaki churna and kanchanar churna along with mulakadi taila uttarbasti in Garbhashaya Arbuda. 
Scientific Title of Study   Randomised Comparative Clinical Study to Evaluate the Efficacy of Gomutra Haritki Churna and Kanchnar Churna along with Mulakadi Taila Uttara Basti on Garbhashaya Arbuda W.S.R to Uterine Fibroid  
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Ritasha Dubey 
Designation  M.S. Scholar 
Affiliation  Mohan Malviya Government Ayurved College Ambamata Udaipur 
Address  P G Department of Prasuti Tantra Evum Striroga Madan Mohan Malviya Government Ayurved College Ambamata Udaipur Udaipur 313001 India

Udaipur
RAJASTHAN
313001
India 
Phone  6376050230  
Fax    
Email  dr.ritasha.dubey@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Narendra Kumar Meena 
Designation  Associate Professor & HOD And Guide 
Affiliation  Madan Mohan Malviya Government Ayurved College Ambamata Udaipur 
Address  P G Department of Prasuti Tantra Evum Striroga Madan Mohan Malviya Government Ayurved College Ambamata Udaipur Udaipur 313001 India

Udaipur
RAJASTHAN
313001
India 
Phone  9950129673  
Fax    
Email  narendermeena42@yahoo.com  
 
Details of Contact Person
Public Query
 
Name  Dr Narendra Kumar Meena 
Designation  Associate Professor & HOD And Guide 
Affiliation  Madan Mohan Malviya Government Ayurved College Ambamata Udaipur 
Address  P G Department of Prasuti Tantra Evum Striroga Madan Mohan Malviya Government Ayurved College Ambamata Udaipur Udaipur 313001 India

Udaipur
RAJASTHAN
313001
India 
Phone  9950129673  
Fax    
Email  narendermeena42@yahoo.com  
 
Source of Monetary or Material Support  
Madan Mohan Malviya Govt. Ayurved College Udaipur,313001,Rajasthan India 
 
Primary Sponsor  
Name  Madan Mohan Malviya Govt. Ayurved College Udaipur 
Address  Madan Mohan Malviya Govt. Ayurved College Udaipur,313001,Rajasthan India 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Ritasha Dubey  Madan Mohan Malviya Govt. Ayurved College Udaipur  O.P.D.No.-5, Prasuti Tantra Evum Stri Roga Department,Udaipur Rajasthan, OPD No.- 6 Prasuti Tantra Evum Striroga Department ,Rajkiya Ayurved Chikitsalaya Moti Chouhatta Udaipur Rajasthan
Udaipur
RAJASTHAN 
06376050230

dr.ritasha.dubey@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
ISTITUTIONAL ETHICS COMMITTEE Madan Mohan Malviya Govt. Ayurved College  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:D259||Leiomyoma of uterus, unspecified. Ayurveda Condition: ARBUDAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmProcedure-bastikarma/, उत्तर-बस्तिः (Procedure Reference: Bhavprakash chikitsa 44/45, Procedure details: a procedure of installation of oil through vaginal route with the help of IUI canulla) with mulkadi taila in the dose of 5 ml for 3 days for 3 consecutive cycle after cessation of menses)))
(1) Medicine Name: Mulkadi Taila, Reference: Bhavprakash chikitsa 44/45, Route: Vaginal, Dosage Form: Taila, Dose: 5(ml), Frequency: od, Duration: 3 Days
2Comparator ArmDrugClassical(1) Medicine Name: KANCHANAR CHURNA, Reference: Bhavprakash nighantu Guduchyadi varga /103-104, Route: Oral, Dosage Form: Churna/ Powder, Dose: 3(g), Frequency: bd, Bhaishajya Kal: Adhobhakta, Duration: 3 Months, anupAna/sahapAna: Yes(details: -Honey), Additional Information: -
3Intervention ArmDrugClassical(1) Medicine Name: GOMUTRA HARITAKI, Reference: Ashtang hridya chikitsa sthan 8/55&56 , Route: Oral, Dosage Form: Churna/ Powder, Dose: 3(g), Frequency: bd, Bhaishajya Kal: Adhobhakta, Duration: 3 Months, anupAna/sahapAna: Yes(details: -honey), Additional Information: -
4Comparator ArmProcedure-uttarabastikarma, उत्तरबस्तिकर्म (Procedure Reference: Bhavprakash chikitsa 44/45, Procedure details: , Procedure details: Uttarbasti (a procedure of installation of oil through vaginal route with the help of IUI canulla) with mulkadi taila in the dose of 5 ml for 3 days for 3 consecutive cycle after cessation of menses))
(1) Medicine Name: Mulkadi Taila, Reference: Bhavprakash chikitsa 44/45,, Route: Vaginal, Dosage Form: Taila, Dose: 5(ml), Frequency: od, Duration: 3 Days
 
Inclusion Criteria  
Age From  30.00 Year(s)
Age To  50.00 Year(s)
Gender  Female 
Details  1.Patient who are willing for trial
2.Single or multiple uterine fibroid
3.The patient either asymptomatic or having clinical sign and symptoms of fibroid.
 
 
ExclusionCriteria 
Details  1.Patient having bleeding due to abortion or any other pathological condition
2.Patients having coagulation disorders.
3.Patient of age less than 30 years and above 50 years
4.Pregnant women
5.Anemic patient whose hemoglobin is below 7 gm.%
6.Patient having any systemic disease like uncontrolled hypertension, diabetes mellitus
7.Patient using IUCDs
8.Having any kind of malignancy.
9.Patient with positive VDRL, HIV, HbsAg,
10.Patients who are contraindicated for Uttar Basti.
11.Large size uterine fibroid with severe menorrhagia and severe pressure symptoms




 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
To compare the effect of trial drug and procedure to Change in the size and volume of uterine fibroid  90 days  
 
Secondary Outcome  
Outcome  TimePoints 
To compare the effect of trial drug and procedure on clinical features of the Garbhashaya Arbuda  90 days 
 
Target Sample Size   Total Sample Size="60"
Sample Size from India="60" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   28/05/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="3"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  
The most common benign tumour of the uterus is the uterine fibroid. Despite not being malignant, it can have a negative impact on women’s overall health and quality of lifeAmong women over 30 years the disease has a 20% prevalence These are more prevalent in nulliparous couples or infertile individuals with one kid. Gynaecologist often deal with uterine fibroids in their daily practice. Oral medication, hormonal therapy, hysterectomy, and other therapeutic techniques are used to treat uterine fibroids, but they are less effective, and patients find it difficult to accept hysterectomy .Due to Modern science limitation,  Ayurveda has great scope in the field to find out effective and invasive approach to manage the disease and improve the quality of life This Study is about to Randomized Comparative Clinical Study to Evaluate the Efficacy of Gomutra Haritaki Churna and Kanchanar Churna along with Mulakadi taila Uttara basti on Garbhashaya Arbuda W.S.R. to Uterine Fibroid There will be Two Group of 30 Patient. Group A Patient will be treated with Gomutra Haritaki Churna 3 gm BD and 5 ml mulkadi  Taila Uttarbasti  Basti (per vaginal) for 3 days for 3 consecutive menstrual cycle. while other 30 patients of group B will be treated with 3 gm BD kanchanar churna and 5 ml mulkadi Taila uttara Basti (per vaginal for 3 days for 3 consecutive menstrual cycle.  This trial study will be carried out for 3 months (90 days) & the follow up of the case will be after every 15 days. Final assessment will be done after completion of 3 months of treatment course on the basis of subjective, objective assessment and laboratory investigations.The data
will be analyzed scientifically and statistically.
 
Close